CORC

在结果中检索

CORC

浏览/检索结果: 共46条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial 期刊论文
2019, 卷号: 25, 期号: 12, 页码: 3486-3494
作者:  Xu, Jianming;  Li, Jie;  Bai, Chunmei;  Xu, Nong;  Zhou, Zhiwei
收藏  |  浏览/下载：23/0  |  提交时间：2020/01/03
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
2019, 卷号: 14, 期号: 5, 页码: 867-875
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
肺癌脑(膜)转移诊断治疗共识 期刊论文
2018, 期号: 04, 页码: 193-200
作者:  吴一龙;  刘晓晴;  毛伟敏;  王启鸣;  冯继锋
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer 期刊论文
2018, 卷号: 9, 期号: 81, 页码: 35284
作者:  Xu Naiqing;  Fang Wenfeng;  Mu Libing;  Tang Yanna;  Gao Lei
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial 期刊论文
2018, 卷号: 6, 期号: 9, 页码: 681-690
作者:  Wang, Zhijie;  Cheng, Ying;  An, Tongtong;  Gao, Hongjun;  Wang, Kai
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients 期刊论文
2018, 卷号: 24, 期号: 13, 页码: 3097-3107
作者:  Yang, Zhe;  Yang, Nong;  Ou, Qiuxiang;  Xiang, Yi;  Jiang, Tao
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 期刊论文
2018, 卷号: 78, 期号: 13
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Osimertinib (AZD9291) in Asia-Pacific Patients with T790M Mutation-Positive Advanced NSCLC: Open-Label Phase II Study Results 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S1250-S1250
作者:  Zhou, Caicun;  Wang, Mengzhao;  Cheng, Ying;  Chen, Yuan;  Zhao, Yanqui
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
BRAIN: A Phase III Trial Comparing WBI and Chemotherapy with Icotinib in NSCLC with Brain Metastases Harboring EGFR Mutations (CTONG 1201) 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S6-S6
作者:  Wu, Yi Long;  Yang, Jin-Ji;  Zhou, Caicun;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace